GLUCAGON AND PHENYLEPHRINE COMBINATION VS GLUCAGON ALONE IN EXPERIMENTAL VERAPAMIL OVERDOSE

Citation
Ck. Stone et al., GLUCAGON AND PHENYLEPHRINE COMBINATION VS GLUCAGON ALONE IN EXPERIMENTAL VERAPAMIL OVERDOSE, Academic emergency medicine, 3(2), 1996, pp. 120-125
Citations number
13
Categorie Soggetti
Emergency Medicine & Critical Care
Journal title
ISSN journal
10696563
Volume
3
Issue
2
Year of publication
1996
Pages
120 - 125
Database
ISI
SICI code
1069-6563(1996)3:2<120:GAPCVG>2.0.ZU;2-H
Abstract
Objective: To evaluate glucagon and phenylephrine in combination as a treatment for the hemodynamic effects of verapamil overdose, Methods: Pentobarbital-anesthetized and instrumented dogs were overdosed using a previously developed verapamil overdose model (15 mg/kg IV over 30 m inutes), The animals were maintained and observed for 90 minutes or un til death. Cardiac output (GO), heart rate (HR), and mean arterial pre ssure (MAP) were monitored, Following the 30-minute verapamil infusion (toxicity), the control animals received no treatment; the glucagon a nimals received a 5-mg glucagon bolus and a drip of 5 mg/90 minutes; a nd the glucagon/phenylephrine animals received the same glucagon thera py plus a phenylephrine drip titrated to 180 mu g/min min over 15 minu tes. The groups were compared using analysis of variance: the experime ntal variables were group and time; the response variables were change s from toxicity for the hemodynamic parameters. Post-hoc comparisons w ere done with a set at 0.05. Results: A significant change in CO was s een in the glucagon group (Delta = 2.6 L/min) and the glucagon/phenyle phrine group (Delta = 1.9 L/min) compared with the control group (Delt a = 0.8 L/min). The change in CO was significantly larger for the gluc agon animals compared with the glucagon/phenylephrine animals. The cha nge in MAP for the glucagon/phenylephrine group (Delta = 24 mm Hg) was significant compared with the control group (Delta = 14 mm Hg). The M AP change for the glucagon group (Delta = 19 mm Hg) was not significan tly different from that of either the control or the glucagon/phenylep hrine group. The change in glucagon HR (Delta = 6 beats/min) was signi ficant compared with the control group (Delta = -4 beats/min) and the glucagon/phenylephrine group (Delta = -4 beats/min). Conclusion: The g lucagon/phenylephrine therapy improved MAP compared with the control, but reduced CO and HR compared with glucagon alone. Glucagon/phenyleph rine therapy is not as effective as glucagon in reversing the hemodyna mic effects of experimental verapamil overdose.